Literature DB >> 8937521

Apolipoprotein E secretion by macrophages: its potential physiological functions.

T Mazzone1.   

Abstract

Results of numerous studies using varied experimental approaches have established a role for macrophage-derived apolipoprotein E in modulating cholesterol balance in the arterial wall, thereby potentially modulating progression or regression of the vessel wall atherosclerotic lesion. Macrophage-derived apolipoprotein E could also act on the vessel wall by modulating the aggregability of platelets and the proliferation of lymphocytes. In addition, macrophage-derived apolipoprotein E interacts with extracellular matrix and such interactions could influence the retention of lipoproteins in the vessel wall, the bioavailability of cytokines and growth factors sequestered in the extracellular matrix and the regulation of arterial smooth muscle cell growth by matrix components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8937521     DOI: 10.1097/00041433-199610000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  23 in total

1.  Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.

Authors:  Zhi H Huang; Catherine A Reardon; Godfrey S Getz; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2014-11-24       Impact factor: 5.922

Review 2.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

3.  Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

Authors:  P Cullen; A Cignarella; B Brennhausen; S Mohr; G Assmann; A von Eckardstein
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 4.  Apolipoprotein E: from lipid transport to neurobiology.

Authors:  Paul S Hauser; Vasanthy Narayanaswami; Robert O Ryan
Journal:  Prog Lipid Res       Date:  2010-09-18       Impact factor: 16.195

Review 5.  Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

Authors:  Ie-Ming Shih; Ben Davidson
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

Review 6.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

7.  ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice.

Authors:  Zhi H Huang; Catherine A Reardon; Papasani V Subbaiah; Godfrey S Getz; Theodore Mazzone
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

8.  FGF-1 induces expression of LXRalpha and production of 25-hydroxycholesterol to upregulate the apoE gene in rat astrocytes.

Authors:  Rui Lu; Jinichi Ito; Noriyuki Iwamoto; Tomoko Nishimaki-Mogami; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-02-19       Impact factor: 5.922

9.  Tumor necrosis factor-alpha-mediated suppression of adipocyte apolipoprotein E gene transcription: primary role for the nuclear factor (NF)-kappaB pathway and NFkappaB p50.

Authors:  Lili Yue; John W Christman; Theodore Mazzone
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

10.  Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma.

Authors:  Y Zhu; S Bellosta; C Langer; F Bernini; R E Pitas; R W Mahley; G Assmann; A von Eckardstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.